Terms: = Pancreatic cancer AND CDX2, CDX3, 1045, ENSG00000165556, Q99626 AND Prognosis
25 results:
1. Relationship Between Immunophenotypes, Genetic Profiles, and Clinicopathologic Characteristics in Small Bowel Adenocarcinoma.
Hoshimoto A; Tatsuguchi A; Yamada T; Kuriyama S; Hamakubo R; Nishimoto T; Omori J; Akimoto N; Gudis K; Mitsui K; Tanaka S; Fujimori S; Hatori T; Shimizu A; Iwakiri K
Am J Surg Pathol; 2024 Feb; 48(2):127-139. PubMed ID: 38062562
[TBL] [Abstract] [Full Text] [Related]
2. cdx2 Is a Prognostic Biomarker for Unresectable Metastatic Colorectal cancer.
Mukohyama J; Agawa K; Yamashita K; Matsuda T; Shinoda M; Itano O; Kakeji Y
Anticancer Res; 2023 Aug; 43(8):3763-3767. PubMed ID: 37500172
[TBL] [Abstract] [Full Text] [Related]
3. The prognostic role of epidermal growth factor receptor mutation in completely resected ampullary adenocarcinoma.
Varol U; Cakır E; Aktas S; Altun ZS; Dilek FH; Butun O; Salman T; Unlu AGD; Alacacioglu A; Somali I
Pol J Pathol; 2023; 74(1):18-28. PubMed ID: 37306349
[TBL] [Abstract] [Full Text] [Related]
4. The role of complement in the clinical course of hepatocellular carcinoma.
Qian X; Yang Z; Gao L; Liu Y; Yan J
Immun Inflamm Dis; 2022 Mar; 10(3):e569. PubMed ID: 34813686
[TBL] [Abstract] [Full Text] [Related]
5. UGT1A Gene Family Members Serve as Potential Targets and Prognostic Biomarkers for pancreatic cancer.
Feng L; Wang Y; Qin J; Fu Y; Guo Z; Zhang J; He G; Jiang Z; Xu X; Zhou C; Gao Y
Biomed Res Int; 2021; 2021():6673125. PubMed ID: 34595239
[TBL] [Abstract] [Full Text] [Related]
6. Expression of CD117, CK17, CK20, MUC4, villin and mismatch repair deficiency in pancreatic intraductal papillary mucinous neoplasm.
Detlefsen S; Jakobsen M; Nielsen MFB; Klöppel G; Mortensen MB
Pathol Res Pract; 2021 Jan; 217():153312. PubMed ID: 33341087
[TBL] [Abstract] [Full Text] [Related]
7. Construction of a 6-gene prognostic signature to assess prognosis of patients with pancreatic cancer.
Yang J; Shi W; Zhu S; Yang C
Medicine (Baltimore); 2020 Sep; 99(37):e22092. PubMed ID: 32925750
[TBL] [Abstract] [Full Text] [Related]
8. pancreatic Intraepithelial Neoplasia (PanIN) as a Morphologic Marker of Pancreatobiliary Type of Ampullary Carcinoma.
Krishnamurthy K; Sriganeshan V
Pathol Oncol Res; 2020 Jul; 26(3):1735-1739. PubMed ID: 31642034
[TBL] [Abstract] [Full Text] [Related]
9. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
[No Abstract] [Full Text] [Related]
10. Intraductal tubulopapillary neoplasm (ITPN) of the pancreas associated with an invasive component: a case report with review of the literature.
Kuscher S; Steinle H; Soleiman A; Öfner D; Schneeberger S; Oberhuber G
World J Surg Oncol; 2017 Nov; 15(1):203. PubMed ID: 29145864
[TBL] [Abstract] [Full Text] [Related]
11. Utilization of cdx2 expression in diagnosing pancreatic ductal adenocarcinoma and predicting prognosis.
Xiao W; Hong H; Awadallah A; Zhou L; Xin W
PLoS One; 2014; 9(1):e86853. PubMed ID: 24489794
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic and therapeutic implications of a novel immunohistochemical panel detecting duodenal mucosal invasion by pancreatic ductal adenocarcinoma.
Sopha SC; Gopal P; Merchant NB; Revetta FL; Gold DV; Washington K; Shi C
Int J Clin Exp Pathol; 2013; 6(11):2476-86. PubMed ID: 24228110
[TBL] [Abstract] [Full Text] [Related]
13. Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin.
Bronsert P; Kohler I; Werner M; Makowiec F; Kuesters S; Hoeppner J; Hopt UT; Keck T; Bausch D; Wellner UF
BMC Cancer; 2013 Sep; 13():428. PubMed ID: 24053229
[TBL] [Abstract] [Full Text] [Related]
14. Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome.
Overman MJ; Zhang J; Kopetz S; Davies M; Jiang ZQ; Stemke-Hale K; Rümmele P; Pilarsky C; Grützmann R; Hamilton S; Hwang R; Abbruzzese JL; Varadhachary G; Broom B; Wang H
PLoS One; 2013; 8(6):e65144. PubMed ID: 23776447
[TBL] [Abstract] [Full Text] [Related]
15. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.
Adsay V; Jang KT; Roa JC; Dursun N; Ohike N; Bagci P; Basturk O; Bandyopadhyay S; Cheng JD; Sarmiento JM; Escalona OT; Goodman M; Kong SY; Terry P
Am J Surg Pathol; 2012 Sep; 36(9):1279-301. PubMed ID: 22895264
[TBL] [Abstract] [Full Text] [Related]
16. Gastric- and intestinal-type marker expression in invasive ductal adenocarcinoma of the pancreas.
Takano Y; Ohike N; Tajiri T; Asonuma K; Harada K; Takahashi H; Morohoshi T
Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):424-8. PubMed ID: 22893471
[TBL] [Abstract] [Full Text] [Related]
17. Immunoprofile of mucinous non-neoplastic cyst of the pancreas.
Zhu B; Lin X
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):265-70. PubMed ID: 22820665
[TBL] [Abstract] [Full Text] [Related]
18. [pancreatic cancer surgery at Ist Surgical Clinic of the Olomouc Faculty Hospital (FN Olomouc)].
Lovecek M; Neoral C; Klos D; Skalický P; Kysucan J; Vrba R; Melichar B; Svébisová H; Tozzi di Angelo I; Kliment M; Havlík R
Rozhl Chir; 2010 Dec; 89(12):731-9. PubMed ID: 21404512
[TBL] [Abstract] [Full Text] [Related]
19. Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases.
Ohike N; Kim GE; Tajiri T; Krasinskas A; Basturk O; Coban I; Bandyopadhyay S; Morohoshi T; Goodman M; Kooby DA; Sarmiento JM; Adsay NV
Am J Surg Pathol; 2010 Dec; 34(12):1731-48. PubMed ID: 21084962
[TBL] [Abstract] [Full Text] [Related]
20. Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours.
Westgaard A; Schjølberg AR; Cvancarova M; Eide TJ; Clausen OP; Gladhaug IP
Histopathology; 2009 Feb; 54(3):337-47. PubMed ID: 19236510
[TBL] [Abstract] [Full Text] [Related]
[Next]
